Validation of the Chinese drug hypersensitivity quality of life questionnaire: Role of delabeling.

Hugo W F MakElsie T S ChanJackie S H YimElaine LeeDorothy L Y LamValerie ChiangPhilip H Li

Published in: Asia Pacific allergy (2023)

The Chinese DrHy-Q is reliable and valid for HRQoL assessment. PA delabeling significantly benefits patients' HRQoL. Future larger-scale studies are warranted to corroborate our findings.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
drug induced
emergency department
patient reported
case control
adverse drug
electronic health record